WCLC 2025 - Posters & ePosters-EP.12.08 A Real-World Study of the Efficacy and Safety of Firmonertinib for Patients With Non-Small Cell Lung Cancer With EGFR Uncommon Mutations

EP.12.08 A Real-World Study of the Efficacy and Safety of Firmonertinib for Patients With Non-Small Cell Lung Cancer With EGFR Uncommon Mutations

Pdf Summary

Summary Not Available

Asset Subtitle

Min Li

Meta Tag

Speaker Min Li

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy